Business
GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million
PHILADELPHIA, January 20, 2026--GSK plc (LSE/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly $1 million to support national, state, and local non-profit organizations working to improve the lives of people impacted by lupus, including systemic lupus erythematosus (SLE) and lupus nephritis (LN).
About this update from Gsk Plc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/6edca521919cf648075751c9d61720fa"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xjit9RyfmVTWqdo_FgpB0w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTk2MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/6edca521919cf648075751c9d61720fa","width":480,"height":480}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Grant funding awarded to support lupus-focused community programs across the United States","length":90,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":90,"olType":false},{"type":"text","content":"PHILADELPHIA, January 20, 2026--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly $1 million to support national, state, and local non-profit organizations working to improve the lives of people impacted by lupus, including systemic lupus erythematosus (SLE) and lupus nephritis (LN).","length":375,"tagName":"p"},{"type":"text","content":"GSK previously sought proposals for community-driven initiatives aimed at improving earlier diagnosis and recognition of lupus signs and symptoms; enhancing awareness of and access to evidence-based treatment options; and/or advancing communication between patients and providers regarding lupus.","length":296,"tagName":"p"},{"type":"text","content":""We’re proud to support these organizations that are deeply embedded in their communities and uniquely positioned to drive meaningful change," Court Horncastle, Senior Vice President at GSK, said. "Their work is essential to improving the lupus journey, from diagnosis to treatment to ongoing care, and we’re honored to help bring their visions to life."","length":374,"tagName":"p"},{"type":"text","content":"Launched in June 2025, the Linked by Lupus: Optimal Care Initiative is part of GSK’s ongoing commitment to improving outcomes for people living with lupus. These efforts align with the initiative’s mission to foster a more connected, informed, and supported lupus community. The selected organizations include 13 grantees from across the country, chosen for their innovative, community-led progr...